These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 34513617)

  • 1. Understanding Hyaluronan Receptor (CD44) Interaction, HA-CD44 Activated Potential Targets in Cancer Therapeutics.
    Chaudhry GE; Akim A; Naveed Zafar M; Safdar N; Sung YY; Muhammad TST
    Adv Pharm Bull; 2021 May; 11(3):426-438. PubMed ID: 34513617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44: structure, function, and association with the malignant process.
    Naor D; Sionov RV; Ish-Shalom D
    Adv Cancer Res; 1997; 71():241-319. PubMed ID: 9111868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression.
    Bourguignon LY; Zhu D; Zhu H
    Front Biosci; 1998 Jul; 3():d637-49. PubMed ID: 9634539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor.
    Platt VM; Szoka FC
    Mol Pharm; 2008; 5(4):474-86. PubMed ID: 18547053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
    Afify A; Purnell P; Nguyen L
    Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct kinetic and molecular requirements govern CD44 binding to hyaluronan versus fibrin(ogen).
    Raman PS; Alves CS; Wirtz D; Konstantopoulos K
    Biophys J; 2012 Aug; 103(3):415-423. PubMed ID: 22947857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer.
    Karousou E; Misra S; Ghatak S; Dobra K; Götte M; Vigetti D; Passi A; Karamanos NK; Skandalis SS
    Matrix Biol; 2017 May; 59():3-22. PubMed ID: 27746219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix Hyaluronan-CD44 Interaction Activates MicroRNA and LncRNA Signaling Associated With Chemoresistance, Invasion, and Tumor Progression.
    Bourguignon LYW
    Front Oncol; 2019; 9():492. PubMed ID: 31293964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and syntheses of hyaluronan oligosaccharide conjugates as inhibitors of CD44-Hyaluronan binding.
    Lu X; Huang X
    Glycoconj J; 2015 Oct; 32(7):549-56. PubMed ID: 25997408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF; Zhu D; Bourguignon LY
    J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the structural perturbations of spliced variants of CD44: a modeling and simulation approach.
    Patel S; Shaikh F; Devaraji V; Radadiya A; Shah K; Shah A; Rawal R
    J Biomol Struct Dyn; 2017 Feb; 35(2):354-367. PubMed ID: 26766750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44: A New Prognostic Marker in Colorectal Cancer?
    Ziranu P; Pretta A; Aimola V; Cau F; Mariani S; D'Agata AP; Codipietro C; Rizzo D; Dell'Utri V; Sanna G; Moledda G; Cadoni A; Lai E; Puzzoni M; Pusceddu V; Castagnola M; Scartozzi M; Faa G
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of CD44 and its variant isoforms in membrane-cytoskeleton interaction, cell adhesion and tumor metastasis.
    Bourrguignon LY; Iida N; Welsh CF; Zhu D; Krongrad A; Pasquale D
    J Neurooncol; 1995 Dec; 26(3):201-8. PubMed ID: 8750186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro culture of human peripheral blood monocytes induces hyaluronan binding and up-regulates monocyte variant CD44 isoform expression.
    Levesque MC; Haynes BF
    J Immunol; 1996 Feb; 156(4):1557-65. PubMed ID: 8568260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
    Bourguignon LYW; Earle C; Shiina M
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion.
    Bourguignon LY; Singleton PA; Diedrich F; Stern R; Gilad E
    J Biol Chem; 2004 Jun; 279(26):26991-7007. PubMed ID: 15090545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer.
    Misra S; Hascall VC; Markwald RR; Ghatak S
    Front Immunol; 2015; 6():201. PubMed ID: 25999946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective Hyaluronan-CD44 Signaling Promotes miRNA-21 Expression and Interacts with Vitamin D Function during Cutaneous Squamous Cell Carcinomas Progression Following UV Irradiation.
    Bourguignon LY; Bikle D
    Front Immunol; 2015; 6():224. PubMed ID: 26029210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 and its implication in neoplastic diseases.
    Xu Y; Bai Z; Lan T; Fu C; Cheng P
    MedComm (2020); 2024 Jun; 5(6):e554. PubMed ID: 38783892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of hyaluronan synthase 2 to promote CD44-dependent oral cavity squamous cell carcinoma progression.
    Wang SJ; Earle C; Wong G; Bourguignon LY
    Head Neck; 2013 Apr; 35(4):511-20. PubMed ID: 22473523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.